167 related articles for article (PubMed ID: 12588510)
1. Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation.
Andrews ZB; Grattan DR
J Neuroendocrinol; 2003 Mar; 15(3):227-36. PubMed ID: 12588510
[TBL] [Abstract][Full Text] [Related]
2. Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation.
Tavakoli-Nezhad M; Arbogast LA
Neuroscience; 2010 Mar; 166(2):359-67. PubMed ID: 20045447
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
Callahan P; Baumann MH; Rabii J
J Neuroendocrinol; 1996 Oct; 8(10):771-6. PubMed ID: 8910807
[TBL] [Abstract][Full Text] [Related]
4. Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy.
Soaje M; Deis RP
Cell Mol Neurobiol; 2004 Apr; 24(2):193-204. PubMed ID: 15176435
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
Baumann MH; Rabii J
Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
[TBL] [Abstract][Full Text] [Related]
6. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Durham RA; Johnson JD; Moore KE; Lookingland KJ
Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
[TBL] [Abstract][Full Text] [Related]
7. Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats.
Zhang B; Hou Y; Voogt JL
Endocrine; 2004 Nov; 25(2):131-6. PubMed ID: 15711026
[TBL] [Abstract][Full Text] [Related]
8. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
Soaje M; Bregonzio C; Carón RW; Deis RP
Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
[TBL] [Abstract][Full Text] [Related]
9. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
12. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
13. Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors.
Dimitrijević M; Stanojević S; Kovacević-Jovanović V; Miletić T; Vujić-Redzić V; Radulović J
Immunopharmacology; 2000 Sep; 49(3):255-62. PubMed ID: 10996023
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of prolactin secretion from tuberoinfundibular dopamine activity in late pregnant rats.
Andrews ZB; Kokay IC; Grattan DR
Endocrinology; 2001 Jun; 142(6):2719-24. PubMed ID: 11356724
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical evidence that estrogen-induced suppression of kappa-opioid-receptor-mediated regulation of tuberoinfundibular dopaminergic neurons is prolactin-independent.
Wagner EJ; Manzanares J; Moore KE; Lookingland KJ
Neuroendocrinology; 1994 Mar; 59(3):197-201. PubMed ID: 7909142
[TBL] [Abstract][Full Text] [Related]
16. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
17. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
Leventhal L; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736
[TBL] [Abstract][Full Text] [Related]
18. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
20. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
